AIM Inhibitor Miransertib in Proteus Syndrome Trial - Trial start Summer 2022.
Phase 2 of the clinical trials will begin this summer at the National Institutes of Health in Bethesda, MD.
For more information: email here or call.
Phase 2 of the clinical trials will begin this summer at the National Institutes of Health in Bethesda, MD.
For more information: email here or call.